Avita Medical Ltd - ADR operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Avita Medical Ltd - ADR with three other
pharmaceutical manufacturers in North America:
Polydex Pharmaceuticals Limited
sales of 6.46 million Canadian Dollars [US$4.89 million]
MEI Pharma Incorporation
of which 100%
was Development of Pharmaceutical compounds), and
Sales increased substantially in 2019:
During the year ended June of 2019, sales at
Avita Medical Ltd - ADR were $5.83 million.
increase of 339.0%
versus 2018, when the company's sales were $1.33 million.
This was the third consecutive year of growth at Avita Medical Ltd - ADR.
Sales of Operating-Americas. saw an increase
that was more than double the company's growth rate: sales were up
1,166.8% in 2019, from
$350,617.71 to $4.44 million.
Not all segments of Avita Medical Ltd - ADR experienced an increase in sales in 2019:
sales of Operating-Emea. fell 31.1% to $260,391.01 .